Discovery of novel R-PTP-sigma inhibitors to promote hematopoietic stem cell regeneration Sep. 5, 2019 No Comments
Shanghai Hengrui Pharmaceutical, Jiangsu Hengrui Medicine disclose F2RL3 antagonists Aug. 23, 2019 No Comments
Rocket announces clearance for phase II registration-enabling FANCOLEN-II study of RP-L102 Aug. 23, 2019 No Comments
China's NMPA approves roxadustat for anemia in patients with CKD not receiving dialysis Aug. 22, 2019 No Comments
Results presented from phase III HOPE study of voxelotor in sickle cell disease Aug. 22, 2019 No Comments
Mitsubishi Tanabe Pharma announces initiation of development of gene therapy for hemophilia B Aug. 6, 2019 No Comments
Pivotal phase III RESET study of rivipansel does not meet primary nor key secondary endpoints Aug. 5, 2019 No Comments
RSS